22-year longitudinal study of repetitive colonoscopy in patients with a family history of colorectal cancer

Annals of the Royal College of Surgeons of England

Volumn 95, Issue 8, 2013, Pages 586-590

  Randall, Jon K ^a   Good, C S ^a   Gilbert, J M ^a  

^a FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adenoma; Colonoscopy; Colorectal cancer; Family history

Indexed keywords

ADENOMA; ADOLESCENT; ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FAMILY HEALTH; FEMALE; GENETICS; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PEDIGREE; RETREATMENT; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FAMILY HEALTH; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEDIGREE; RETREATMENT; YOUNG ADULT;

EID: 84891657662     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/rcsann.2013.95.8.586     Document Type: Article

References (18)

1. Fuchs CS, Giovannucci EL, Colditz GA et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331: 1,669-1,674.
2. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah Population Database. J Natl Cancer Inst 1994; 86: 1,618-1,626.
3. Dunlop MG. Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years. Gut 2002; 51: v17-v20.
4. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000; 343: 162-168.
5. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51: v6-v9.
6. Stryker SJ, WolffBG, Culp CE et al. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1,009-1,013.
7. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut 2010; 59: 666-689.
8. Winawer SJ, Zauber AG, O'Brien MJ et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328: 901-906.
9. Gilbert JM, Vaizey CJ, Cassell PG, Holden J. Feasibility study of colonoscopy as the primary screening investigation in relatives of patients with colorectal cancer. Ann R Coll Surg Engl 2001; 83: 415-419.
10. Banerjea A, Clark S, Dorudi S. The changing face of familial colorectal cancer. BMJ 2005; 330: 2-3.
11. Bradshaw N, Holloway S, Penman I et al. Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut 2003; 52: 1,748-1,751.
12. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696.
13. Bressler B, Paszat LF, Vinden C et al. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology 2004; 127: 452-456.
14. Dove-Edwin I, Sasieni P, Adams J, Thomas HJ. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005; 331: 1,047.
15. Weissfeld JL Schoen RE, Pinsky PF et al. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst 2012; 104: 280-289.
16. Stephenson BM, Murday VA, Finan PJ et al. Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut 1993; 34: 96-100.
17. Puente Gutiérrez JJ, Marín Moreno MA, Domínguez Jiménez JL et al. Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer. Colorectal Dis 2011; 13: e145-e153.
18. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1,472-1,477.